| GENT is a microcap biotech company, based in Italy, with a purified DNA drug called defibrotide, which has been studied extensively in VOD and really seems to work. At the time I created this board, it's in phase 3 in the US for treatment of VOD, and in phase 3 in Europe for prevention of VOD. VOD is veno-occlusive disease, an often-fatal complication of hematopoietic cell transplantation. It seems to be more common now than previously, which is coincident with the increase in peripheral stem cell transplant, but also there are other drugs used now, such as hematopoietic growth factors, that might also be implicated. Regardless, if this drug works it's a shoo-in for approval and use, and it will command a premium price. |
